Croatian(HR)English (United Kingdom)

HDIR__10godinaOve godine Hrvatsko društvo za istraživanje raka (HDIR) slavi značajnu obljetnicu - u svibnju 2019. g. se navršava prvih deset godina od osnivanja HDIR-a! 

Još uvijek smo mlado društvo koje je od tridesetak individualnih članova European Association for Cancer Research (EACR) naraslo na preko 200 članova. Naš rast je značajan i to s ponosom ističemo u našoj krovnoj organizaciji EACR-u. 

U proteklih deset godina možemo se pohvaliti izuzetno dobrom aktivnošću - iza nas je pet konferencija s međunarodnim sudjelovanjem te jedan simpozij s vrhunskim svjetskim predavačima, nekoliko radionica i brojna predavanja.

Našu desetogodišnju obljetnicu odlučili smo obilježiti prigodnim jednodnevnim simpozijem koji će biti posvećen mlađim članovima našeg Društva i koji će tom prigodom predstaviti svoja istraživanja.

Simpozij će se održati 4. lipnja 2019. g. u predavaonici III. krila Instituta "Ruđer Bošković".

Sudjelovanje na simpoziju je besplatno i otvoreno za sve zainteresirane.


eacrCroatian Association for Cancer Research (CACR) is the association which brings together scientific and professional employees who are engaged in scientific and professional work in medicine, biology, biochemistry and related scientific fields related to cancer. The Society operates as a branch of the European Association for Cancer Research (EACR). EACR acts for 46 years and it is the most powerful European non-profit professional organization that covers both clinical and basic aspects of cancer research. Today there are over 10,000 members from about 90 countries worldwide. Membership of EACR forms individual members and national societies. There are over 170 members from Croatia registered to EACR, and Croatia is the only follower of the countries of the former state that has managed to keep representatives in the EACR Council. Council Committee is one of the main bodies of the Society, made by 25 members of the EACR who represent a particular country or their society. All EACR members from Croatia also become members of the Croatian Association for Cancer Research. Equally, all new members of the Croatian Association for Cancer Research automatically become members of the EACR.

The main objectives of the Croatian Association for Cancer Research are: 

a)  encouraging scientific and professional work in medicine, biology, biochemistry and related fields of science related to cancer research

b)  linking clinical and basic aspects of cancer research 

c)  promoting and enhancing communication among various groups by encouraging multidisciplinary program

d) encouraging initiatives for research programs of special importance to the area of cancer.

These guidelines are consistent with the mission of EACR, which aims to promote basic research with clearer directions to the prevention and treatment and care of cancer patients and whose members are active scientist, students, Emeriti, notables in areas related in any way with cancer, different aspects of cancer research, applications research and management.

CACR gives us a greater possibility of cooperation with related national organizations for cancer research in other countries in Europe and the world (BACR, ASEICA, MOT, AACR, etc.). In addition, we wish to strengthen connections between members of EACR in Croatia, but primarily to link researchers and as the Society to gain recognition in the field of cancer research as well as to enhance accessibility of the Society for young researchers.



Basic cancer research: why is it essential for the success of personalised cancer therapy?


The last decade has witnessed significant progress in cancer understanding and therapy: we can now identify the genetic drivers of individual tumours, and tailor drugs able to specifically intercept the driver mutations. While all agree that personalised cancer medicine is a clear outcome of the resources dedicated to cancer research over the last 50 years, some critics question the necessity for continuous investments in sub-fields other than clinical research and drug development. Herein, scientists from the European Association for Cancer Research (EACR) argue that the new ways to diagnose and treat cancer present important and hitherto unaddressed challenges for fundamental research of cancer. Allocating the resources needed for basic studies will likely fuel the next wave of achievements in the long way to conquer cancer.

Yosef Yarden and Carlos Caldes,

on behalf of the European Association for Cancer Research


Click here to read the 2-page position paper (reprinted in the 2014 EACR Yearbook)